Long-term usage of darbepoetin alpha in non-dialysis CKD patients

Next Previous
Trial Profile

Long-term usage of darbepoetin alpha in non-dialysis CKD patients

Completed
Phase of Trial: Phase IV

Latest Information Update: 12 Aug 2016

At a glance

  • Drugs Darbepoetin alfa (Primary)
  • Indications Anaemia
  • Focus Adverse reactions
  • Acronyms DREAM-J
  • Sponsors Kyowa Hakko Kirin

    • Most Recent Events

    • 03 Aug 2016 Status changed from active, no longer recruiting to completed.
    • 27 Apr 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top